If you need medical help and are unsure what to do, call NHS 111 for help and advice. They are available 24 hours a day.
APC Prescribing Guidelines
- APC PG 001 - For the treatment and prevention of Venous Thromboembolic disease (DVT/PE)
- APC PG 002 - Azathioprine/6-Mercaptopurine for the treatment of Inflammatory Bowel Disease (IBD)
- APC PG 003 - Azathioprine for the treatment of inflammatory joint disease
- APC PG 004 - Ciclosporin for the treatment of inflammatory joint disease
- APC PG 005 - Cinacalcet for the treatment of secondary hyperparathyroidism
- APC PG 006 - Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures
- APC PG 007 - Fidaxomicin for the treatment of recurrent Clostridium difficile infection (CDI)
- APC PG 008 - Gold therapy for the treatment of inflammatory joint disease
- APC PG 009 - Leflunomide for the treatment of inflammatory joint disease
- APC PG 010a - Lithium Prescribing Arrangements
- APC PG 011 - BHFT Melatonin Prescribing Arrangements
- APC PG 012 - BHFT Methadone for refractory pain
- APC PG 013 - Mycophenolate mofetil (MMF) for the treatment of inflammatory joint disease
- APC PG 014 - Non-calcium based binders Lanthanum Carbonate and Sevelamer Carbonate or Hydrochloride for the treatment of hyperphosphatemia in adults with chronic kidney disease
- APC PG 015a - Cholinesterase Inhibitors / Memantine Prescribing Arrangements
- APC PG 016 - Prescribing Arrangements for Patients Prescribed Long Acting Injectable (LAI) Antipsychotics
- APC PG 017 - Primary care prescribing arrangements for midodrine (Bramox®) for use in orthostatic hypotension and Postural Tachycardia Syndrome (PoTS)
- APC PG 018 - Methotrexate for the treatment of Inflammatory Bowel Disease
- APC PG 019 - Mycophenolate Mofetil for the treatment of lupus nephritis and systemic vasculitis
- APC PG 020 - Sacubitril valsartan for the treatment of symptomatic heart failure
- APC PG 021 - Prescribing Guideline for amantadine for the treatment of fatigue in Multiple Sclerosis
- APC PG 022 - Azathioprine for the treatment of vasculitis
- APC PG 023 - Methotrexate for the treatment of vasculitis
- APC PG 024 - Tacrolimus for the treatment of Nephrotic Syndrome
- APC PG 025 - Rheumatology Department DMARD Monitoring Guidelines for Methotrexate
- APC PG 026 - Hydroxycarbamide for Polycythaemia Vera, Myelofibrosis and Essential Thrombocythaemia
- APC PG 027 - Nebulised tobramycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis, intolerant of, or deterioration on, long term nebulised Colomycin
- APC PG 028 - Nebulised colomycin for the treatment Pseudomonas colonised (non cystic fibrosis) bronchiectasis
- APC PG 029 - Human Growth Hormone (somatropin)
- APC PG 030 - The use of GnRH Agonists in Central Precocious Puberty (CPP)
- APC PG 031 - Topical tacrolimus (Protopic) for the treatment of moderate to severe atopic dermatitis in adults not responding to conventional therapies
- APC PG 032 - Tinzaparin for Prophylaxis of Venous Thromboembolism during Pregnancy and the Puerperium
- APC PG 033 - Tacrolimus for the treatment of Inflammatory Bowel Disease (IBD)
- APC PG 034 - Sucroferric Oxyhydroxide
- APC PG 035a - Prescribing Guidelines for drugs in children with ADHD with transition to adult services in Berkshire
- APC PG 036a - Prescribing Guidelines for the use of drugs in adult ADHD in Berkshire